US2010233208A1PendingUtilityA1

Methods of Treating and Preventing Neurological Symptoms Caused by Avian Reovirus and Novel Associated Characteristics

Assignee: INTERVET INT BVPriority: Oct 9, 2002Filed: May 25, 2010Published: Sep 16, 2010
Est. expiryOct 9, 2022(expired)· nominal 20-yr term from priority
A61P 31/12A61P 37/02A61P 31/14C12N 7/00A61P 25/00A61K 2039/545A61K 39/12A61K 2039/5252C12N 2720/12034A61K 39/15A61K 2039/5254
38
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Embodiments of the present invention generally relate to novel methods for the treatment and/or prevention of neurological symptoms caused by an avian reovirus, enteric reovirus strain (ERS), and associated characteristics. Other embodiments generally comprise and immunogenic composition or vaccine comprising an ERS for the treatment and/or prevention of neurological symptoms.

Claims

exact text as granted — not AI-modified
1 - 13 . (canceled) 
   
   
       14 . An immunogenic composition comprising an enteric reovirus strain selected from the group consisting of strain ERS 060E (ATCC Deposit number PTA-4782), strain ERS 074 (ATCC Deposit number PTA-4783), and strain ERS 1037 (ATCC Deposit number PTA-4735). 
   
   
       15 . The immunogenic composition or vaccine of  claim 14 , wherein the immunogenic composition further comprises a vaccine strain of at least one of Marek's Disease Virus, Infectious Bursal Disease Virus, Newcastle Disease Virus, Infectious Bronchitis Virus, Avian Encephalomyelitis Virus, Fowl Pox Virus, and Chicken Anemia Agent. 
   
   
       16 - 18 . (canceled) 
   
   
       19 . An avian reovirus ERS selected from the group consisting of strain ERS 060E, strain ERS 074, and strain ERS 1037.

Join the waitlist — get patent alerts

Track US2010233208A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.